Global medical cannabis leader proud to help Croatian patients in need.

Tilray, a global leader in medical cannabis research and production, today announced that the company has shipped precisely crafted medical cannabis products to Croatia to be dispensed to patients with prescriptions via pharmacies. This marks the first time medical cannabis products containing the active compound tetrahydrocannabinol (THC) are being legally imported into the European Union from North America for commercial medical use. It marks another strategic milestone for Tilray as the company aims to build the world's most trusted and admired medical cannabis brand by offering patients, physicians, researchers and pharmacies pure, precise and predictable products.

Tilray is supplying pharmacies around Croatia with orally administered medical cannabis products through a partnership with the Croatian Institute of Immunology, which will oversee distribution of Tilray products cultivated and processed at the company's federally licensed, state-of-the-art production facility in Canada. After...